microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection.

OBJECTIVE We previously performed a meta-analysis of microRNA profiling studies on head and neck/oral cancer (HNOC), and identified 11 consistently dysregulated microRNAs in HNOC. Here, we evaluate the diagnostic values of these microRNAs in oral tongue squamous cell carcinoma (OTSCC) using oral cytology samples. MATERIALS AND METHODS The levels of 11 microRNAs were assessed in 39 oral cytology samples (19 OTSCC and 20 normal subjects), and 10 paired OTSCC and adjacent normal tissues. The predictive power of these microRNAs was analyzed by receiver operating characteristic curve (ROC) and random forest (RF) model. A classification and regression trees (CART) model was generated using miR-21 and miR-375, and further validated using both independent oral cytology validation sample set (14 OTSCC and 11 normal subjects) and tissue validation sample set (12 paired OTSCC and adjacent normal tissues). RESULTS Differential expression of miR-21, miR-100, miR-125b and miR-375 was validated in oral cytology training sample set. Based on the RF model, the combination of miR-21 and miR-375 was selected which provide best prediction of OTSCC. A CART model was constructed using miR-21 and miR-375, and was tested in both oral cytology and tissue validation sample sets. A sensitivity of 100% and specificity of 64% was achieved in distinguishing OTSCC from normal in the oral cytology validation set, and a sensitivity of 83% and specificity of 83% was achieved in the tissue validation set. CONCLUSION The utility of microRNA from oral cytology samples as biomarkers for OTSCC detection is successfully demonstrated in this study.

[1]  A. Kolokythas,et al.  A prototype tobacco-associated oral squamous cell carcinoma classifier using RNA from brush cytology. , 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  A. Kolokythas,et al.  Analysis of RNA from brush cytology detects changes in B2M, CYP1B1 and KRT17 levels with OSCC in tobacco users. , 2011, Oral oncology.

[3]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[4]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[5]  Baosheng Li,et al.  The expression of miR-21 and miR-375 predict prognosis of esophageal cancer. , 2014, Biochemical and biophysical research communications.

[6]  Zengtong Zhou,et al.  MicroRNA‐155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential , 2015, Head & neck.

[7]  Xing-Xing He,et al.  The emerging role of miR‐375 in cancer , 2014, International journal of cancer.

[8]  J. M. Thomson,et al.  MicroRNA expression profiles in head and neck cancer cell lines. , 2007, Biochemical and biophysical research communications.

[9]  A. Statnikov,et al.  Molecular Characterization of the Peripheral Airway Field of Cancerization in Lung Adenocarcinoma , 2015, PloS one.

[10]  J. Inazawa,et al.  Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.

[11]  S. D. Selcuklu,et al.  miR-21 as a key regulator of oncogenic processes. , 2009, Biochemical Society transactions.

[12]  D. Ichikawa,et al.  Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma , 2012, Expert opinion on biological therapy.

[13]  Siyi Li,et al.  Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies , 2015, Tumor Biology.

[14]  Anna M. Krichevsky,et al.  miR-21: a small multi-faceted RNA , 2008, Journal of cellular and molecular medicine.

[15]  R. Fåhraeus,et al.  Downregulation of miRNA-424: a sign of field cancerisation in clinically normal tongue adjacent to squamous cell carcinoma , 2015, British Journal of Cancer.

[16]  Hung-Ming Wang,et al.  Oncogenic Function and Early Detection Potential of miRNA-10b in Oral Cancer as Identified by microRNA Profiling , 2012, Cancer Prevention Research.

[17]  B. Xiao,et al.  miR-21, miR-106b and miR-375 as novel potential biomarkers for laryngeal squamous cell carcinoma. , 2014, Current pharmaceutical biotechnology.

[18]  A. Kolokythas,et al.  Similar Squamous Cell Carcinoma Epithelium microRNA Expression in Never Smokers and Ever Smokers , 2015, PloS one.

[19]  A. Borges,et al.  Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. , 1989, American journal of surgery.

[20]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[21]  J. Schwartz,et al.  RNA from brush oral cytology to measure squamous cell carcinoma gene expression. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[22]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[23]  D. Kupfer,et al.  Examining smoking-induced differential gene expression changes in buccal mucosa , 2010, BMC Medical Genomics.

[24]  Lihe Zhang,et al.  Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5 , 2015, Oncotarget.

[25]  N. Seki,et al.  Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. , 2012, International journal of oncology.

[26]  Dongsheng Yu,et al.  Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. , 2012, Oral oncology.

[27]  A. Guimarães,et al.  Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. , 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[28]  Yuanjia Tang,et al.  miR-21 and miR-375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival. , 2014, American journal of translational research.

[29]  R. Spiro,et al.  Improved survival in the treatment of squamous carcinoma of the oral tongue. , 1993, American journal of surgery.

[30]  A. Schetter,et al.  MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival , 2009, Clinical Cancer Research.

[31]  Yuanjia Tang,et al.  MiR-21/miR-375 ratio is an independent prognostic factor in patients with laryngeal squamous cell carcinoma. , 2015, American journal of cancer research.

[32]  V. Backman,et al.  Buccal microRNA dysregulation in lung field carcinogenesis: Gender-specific implications , 2014, International journal of oncology.

[33]  S. Spivack,et al.  Gene-Environment Interaction Signatures by Quantitative mRNA Profiling in Exfoliated Buccal Mucosal Cells , 2004, Cancer Research.

[34]  N. De Sarkar,et al.  A Quest for miRNA Bio-Marker: A Track Back Approach from Gingivo Buccal Cancer to Two Different Types of Precancers , 2014, bioRxiv.

[35]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[36]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[37]  J. Manni Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. , 1997, Head & neck.

[38]  William Ignace Wei,et al.  Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.

[39]  Chung-Ji Liu,et al.  MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder. , 2016, Oral oncology.

[40]  P. Levine,et al.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. , 2002, Archives of otolaryngology--head & neck surgery.

[41]  Ming-Yu Yang,et al.  Circulating miRNA is a novel marker for head and neck squamous cell carcinoma , 2012, Tumor Biology.

[42]  John P A Ioannidis,et al.  Clinical outcome prediction by microRNAs in human cancer: a systematic review. , 2012, Journal of the National Cancer Institute.